On Thursday, Shares of Citigroup Inc (NYSE:C), lost -0.57% to $55.36.
Citigroup Inc, launched the Citi Bike Sweepstakes, a social media campaign centered on the new Mets-wrapped Citi Bikes, which will be in market for the month of July. Every day, from July 1st to July 29th, fans will have the opportunity to win special Citi Perks and Mets-themed prizes, counting game tickets and branded backpacks and baseball hats. At the conclusion of the sweepstakes, one participant will win the chance to throw out the first pitch at Citi Field®.
Mets outfielder Curtis Granderson and Mrs. Met joined Citi’s Head of Global Public Affairs Ed Skyler in Central Park recently to kick-off the month-long campaign. To enter the sweepstakes, fans will need to take a photo of one of 50 Mets-wrapped bicycles that are placed across Citi Bike stations in the city and share on Twitter or Instagram using #CitiBikeSweepstakes. One winner will be selected at random each day for the duration of the Citi Bike Sweepstakes.
Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide.
Shares of SunPower Corporation (NASDAQ:SPWR), declined -1.47% to $27.49, during its last trading session.
SunPower Corporation, declared that on July 31, 2015, it will redeem the entire $79,000 outstanding principal amount of its 0.75% Senior Convertible Debentures due in 2027 (CUSIP No. 867652 AB 5). SunPower intends to use accessible funds to redeem the debentures.
SunPower Corporation designs, manufactures, and delivers solar systems to residential, commercial, and utility-scale power plant customers worldwide. The company offers solar power components, counting panels, balance of system components, and inverters.
Finally, Unilife Corp (NASDAQ:UNIS), ended its last trade with -4.76% loss, and closed at $2.00.
Unilife Corp, declared that its debt agreement with OrbiMed has been amended as of June 30, 2015. This amendment removed a covenant that required Unilife to generate at least $20 million in cash receipts from customers during the six months ended June 30, 2015. There were no other adjustments to any of the terms of the debt agreement as part of this amendment.
Additionally, Unilife declared that it recorded $5.5 million and $14.4 million in unaudited cash receipts for the three and six month periods ended June 30, 2015, respectively.
Mr. Alan Shortall, Chairman and Chief Executive of Unilife, said: “Unilife continues to enjoy a strong partnership with OrbiMed. The business fundamentals of Unilife remain on track. As we have said formerly, our cash receipts may be lumpy on a quarter to quarter basis, as reflected by our cash receipts for the fiscal 2015 fourth quarter. We continue to expand our cleanroom facilities in York, PA and enhance our production capacities in line with customer demand. Negotiations for additional agreements with existing and other prospective customers seeking access to products from across our portfolio continue to advance favorably, with some of these agreements predictable to comprise upfront payments.”
Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
